These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1333551)

  • 1. Intracellular pH and Na+/H+ antiport activity of cultured skin fibroblasts from diabetics.
    Davies JE; Ng LL; Kofoed-Enevoldsen A; Li LK; Earle KA; Trevisan R; Viberti G
    Kidney Int; 1992 Nov; 42(5):1184-90. PubMed ID: 1333551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Na+/H+ antiport activity and cell growth in cultured skin fibroblasts of IDDM patients with nephropathy.
    Trevisan R; Li LK; Messent J; Tariq T; Earle K; Walker JD; Viberti G
    Diabetes; 1992 Oct; 41(10):1239-46. PubMed ID: 1327925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leucocyte Na+/H+ antiport activity in type 1 (insulin-dependent) diabetic patients with nephropathy.
    Ng LL; Simmons D; Frighi V; Garrido MC; Bomford J; Hockaday TD
    Diabetologia; 1990 Jun; 33(6):371-7. PubMed ID: 2165946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferation and Na+/H+ antiport activity in human fibroblasts from type I diabetic patients with nephropathy.
    Soussan K; Dausse E; Hannedouche T; Timsit J; Lemoult F; Boitard C; Grünfeld JP; Guicheney P
    Am J Hypertens; 1993 Feb; 6(2):170-3. PubMed ID: 8385959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-dependent diabetic sibling pairs are concordant for sodium-hydrogen antiport activity.
    Trevisan R; Fioretto P; Barbosa J; Mauer M
    Kidney Int; 1999 Jun; 55(6):2383-9. PubMed ID: 10354286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal Na+/H+ antiport activity in cultured fibroblasts from NIDDM patients with hypertension and microalbuminuria.
    Trevisan R; Cipollina MR; Duner E; Trevisan M; Nosadini R
    Diabetologia; 1996 Jun; 39(6):717-24. PubMed ID: 8781768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of protein kinase C modulators on the leucocyte Na+/H+ antiport in type 1 (insulin-dependent) diabetic subjects with albuminuria.
    Ng LL; Simmons D; Frighi V; Garrido MC; Bomford J
    Diabetologia; 1990 May; 33(5):278-84. PubMed ID: 2165458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormalities in Na+/H+ antiporter activity in diabetic nephropathy.
    Ng LL; Davies JE
    J Am Soc Nephrol; 1992 Oct; 3(4 Suppl):S50-5. PubMed ID: 1333834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipids and cellular Na+/H+ antiport activity in diabetic nephropathy.
    Ng LL; Davies JE
    Kidney Int; 1992 Apr; 41(4):872-6. PubMed ID: 1325009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet Na+/H+ antiport activity in patients with insulin-dependent diabetes mellitus with and without diabetic nephropathy.
    Düsing R; Sorger M; Mattes L; Göbel BO; Hoffmann G; Rosskopf D; Vetter H; Siffert W
    Clin Investig; 1993 Feb; 71(2):119-25. PubMed ID: 8384910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Na(+)-H+ antiport activity in skin fibroblasts from blacks and whites.
    Hatori N; Gardner JP; Tomonari H; Fine BP; Aviv A
    Hypertension; 1990 Feb; 15(2):140-5. PubMed ID: 2154402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth phenotype of cultured skin fibroblasts from IDDM patients with and without nephropathy and overactivity of the Na+/H+ antiporter.
    Lurbe A; Fioretto P; Mauer M; LaPointe MS; Batlle D
    Kidney Int; 1996 Nov; 50(5):1684-93. PubMed ID: 8914037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of heat on Na+/H+ antiport function and survival in mammalian cells.
    Liu FF; Diep K; Tannock IF; Hill RP
    Int J Radiat Oncol Biol Phys; 1996 Feb; 34(3):623-34. PubMed ID: 8621287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth factor action and intracellular pH regulation in fibroblasts. Evidence for a major role of the Na+/H+ antiport.
    L'Allemain G; Paris S; Pouysségur J
    J Biol Chem; 1984 May; 259(9):5809-15. PubMed ID: 6325450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refined estimation of kinetic parameters of the Na+/H+ antiport in human fibroblasts and platelets.
    Gardner JP; Tokudome G; Tomonari H; Aladjem M; Cragoe E; Aviv A
    Proc Soc Exp Biol Med; 1990 Jun; 194(2):165-71. PubMed ID: 2161542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose-induced changes in turnover of Na+/H+ exchanger of immortalized lymphoblasts from type I diabetic patients with nephropathy.
    Davies JE; Siczkowski M; Sweeney FP; Quinn PA; Krolewski B; Krolewski AS; Ng LL
    Diabetes; 1995 Apr; 44(4):382-8. PubMed ID: 7698504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asymmetric affinity of Na+-H+ antiporter for Na+ at the cytoplasmic versus external transport site.
    Goldfarb D; Nord EP
    Am J Physiol; 1987 Nov; 253(5 Pt 2):F959-68. PubMed ID: 2825541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simvastatin and intracellular pH regulation by the Na+/H+ antiport of SV40-virus-transformed human MRC5 fibroblasts.
    Davies JE; Ng LL
    Clin Sci (Lond); 1993 Jun; 84(6):633-43. PubMed ID: 8392920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukocyte intracellular pH and Na/H antiporter activity in uraemia and type I diabetes mellitus.
    Poli de Figueiredo CE; Ng LL; Garrido MC; Davies JE; Ellory JC; Hendry BM
    Nephrol Dial Transplant; 1991; 6(9):615-20. PubMed ID: 1660575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A specific mutation abolishing Na+/H+ antiport activity in hamster fibroblasts precludes growth at neutral and acidic pH.
    Pouysségur J; Sardet C; Franchi A; L'Allemain G; Paris S
    Proc Natl Acad Sci U S A; 1984 Aug; 81(15):4833-7. PubMed ID: 6087349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.